Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

22.09.2025

2 Br J Cancer
1 Clin Cancer Res
3 Gynecol Oncol
1 Int J Cancer
1 PLoS Genet



    Br J Cancer

  1. WU R, Arendse KD, Hamdani T, Walter FM, et al
    Cost-effectiveness of CA125- and age-informed risk-based triage for ovarian cancer detection in primary care.
    Br J Cancer. 2025 Sep 17. doi: 10.1038/s41416-025-03166.
    >> Share

  2. ARENDSE KD, Walter FM, Abel G, Rous B, et al
    CA125 and age-based models for ovarian cancer detection in primary care: a population-based external validation study.
    Br J Cancer. 2025 Sep 17. doi: 10.1038/s41416-025-03165.
    >> Share


    Clin Cancer Res

  3. NGOI NYL, Choi CH, Zhu J, Lim D, et al
    Durvalumab versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): a multicenter, randomized, phase 2 trial.
    Clin Cancer Res. 2025 Jul 24. doi: 10.1158/1078-0432.CCR-25-0201.
    >> Share


    Gynecol Oncol

  4. CLARKE MA, Wentzensen N, Kobel M, Erickson BK, et al
    Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019.
    Gynecol Oncol. 2025;200:137-144.
    >> Share

  5. BRODSKY AL, Sun C, Cobb L, Westin SN, et al
    Ovarian mixed low- and high-grade serous carcinoma as a synchronous or metachronous phenomenon: A clinicopathologic study of 39 cases.
    Gynecol Oncol. 2025;200:130-136.
    >> Share

  6. HUBINETTE M, Sundstrom-Poromaa I, Persson S, Elenis E, et al
    Polycystic ovary syndrome and the risk of ovarian tumours.
    Gynecol Oncol. 2025;200:1-7.
    >> Share


    Int J Cancer

  7. ULLAH A, Chen Y, Shen Y, Shen B, et al
    Chemotherapy as a double-edged sword: Modulation of tumor-associated cytokine and chemokine responses in ovarian cancer.
    Int J Cancer. 2025 Sep 15. doi: 10.1002/ijc.70132.
    >> Share


    PLoS Genet

  8. KIM H, Kim Y, Park J, Shin DM, et al
    Integrative transcriptomic analysis of Korean high-grade serous ovarian cancer.
    PLoS Genet. 2025;21:e1011660.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016